DEXCOM INC (DXCM)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenue | 1,157,100 | 1,036,000 | 994,200 | 1,004,300 |
| Cost of sales | 468,300 | 447,000 | 400,400 | 377,600 |
| Gross profit | 688,800 | 589,000 | 593,800 | 626,700 |
| Selling, general and administrative | 328,000 | 310,100 | 306,400 | 332,700 |
| Research and development | 148,200 | 145,200 | 135,400 | 136,000 |
| Total operating expenses | 476,200 | 455,300 | 441,800 | 468,700 |
| Operating income | 212,600 | 133,700 | 152,000 | 158,000 |
| Other income, net | 28,500 | 20,600 | 25,400 | 29,800 |
| Income before income taxes | 241,100 | 154,300 | 177,400 | 187,800 |
| Income tax expense | 61,300 | 48,900 | 42,800 | 44,300 |
| Net income | 179,800 | 105,400 | 134,600 | 143,500 |
| Basic net income per share (in usd per share) | 0.46 | 0.27 | 0.34 | 0.36 |
| Diluted net income per share (in usd per share) | 0.45 | 0.27 | 0.34 | 0.35 |
| Shares used to compute basic net income per share (in shares) | 392,100,000 | 391,100,000 | 394,200,000 | 399,200,000 |
| Shares used to compute diluted net income per share (in shares) | 408,200,000 | 407,500,000 | 410,200,000 | 416,800,000 |